Notes

Aff)
(1) more accessible <----------can't make if they have no money, supply can't meet demand
price increase <-------innovation affects new drugs worldwide
companies can raise price<---------competition<------------------ no negotiations
10% year increase <------- lower else ware
1 in 5 generic have increase up to a 1000%<---------Insurance decrease the prices
patent drugs are lower in other nations
1) more affordable <----------------------------------- AARP : Private negotiators<--companies losing money right now
Patients skip buying cause of $$ <------------------Giving it out for free
45 million americans didn't fill prescriptions <---------- there has been an increase in R+D price
125,000 from non-adherence <----------------In general, could be referring to anti-vax<----- not true
20% decrease in prices = 20% increase in people access
2) lower premiums<-------------------surgeries cost a lot, most costly <---------less sick
reduce the price of the healthcare <-------------innovation means you don't need to go to hospital<---- only if they win their case
44 million have no insurance <--------------------no brightline for drug costs
care and checkups decrease <----------- 18-27 billion drop in revenue
reduce insurance by 42% because of cost
7 out of 10 deaths are chronic
3) safety net clinics <----- always fail<-------------- 1) not profit driven, made by rich people
2) can't afford the new drugs.
83% cant secure healthcare without
costs hurt viability of clinics
clinics need the money
most clinics don't get gov revenue
decreased mortality by 2%
_________________________________________________________________________________________________________________________________________Neg)
1) R+D <----- 1% decrease in prices
1) direct cuts<--------------- less R+D prices have been going down, 1) either non-unique or de-link
cut investment profits
forced to charge less for drugs<------------------still making hella profit
limits net profit
40-45% in prices
2) less desirable<---------- government are the people who pay
investors don't have incentive
more wages
1) lower advertisers<----------not gonna switch over to make shoes
5.2 billion dollars
62% since 2012<-----------doctors
adds are highly valued source
spread info
lack of information
1) decrease R+D
2.7 billion
1-10 are FDA
high risk high reward
700,000 die from antibiotics
very risky
destroy incentive
1/3 fewer drugs